Markets

Weakness Seen in Radius Health (RDUS): Stock Tumbles 12%

Radius Health, Inc.RDUS saw a big move last session, as the company's shares fell by over 12% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This continues the recent downtrend for RDUS, as the stock is now down nearly 31% since Jan 4.

This slump shouldn't be too much of a surprise to investors, as the biopharmaceutical company has seen 1 negative revisions in the past few weeks and its current year earnings consensus has moved lower over the last 60 days. This suggests there may be more trouble down the road.

So make sure to keep an eye on this stock going forward to see if this recent slump will continue, as the earnings picture definitely suggests that this might be the case.

RDUS currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00.

A better-ranked stock in the retail sector is Aerie Pharmaceuticals, Inc. AERI , which currently carries a Zacks Rank #1 (Strong Buy).

Is RDUS going up? Or down? Predict to see what others think:

Up or Down

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

AERIE PHARMACT (AERI): Free Stock Analysis Report

RADIUS HEALTH (RDUS): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

RDUS AERI

Other Topics

Investing Stocks

Latest Markets Videos

Zacks

Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.

Learn More